405 results
8-K
EX-99.1
6fla2ubk2 v7f7p
26 Apr 24
AbbVie Reports First-Quarter 2024 Financial Results
7:43am
8-K
z9tmei2
3 Apr 24
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:06pm
8-K
EX-4.2
oyaacxrs larq55k
26 Feb 24
Other Events
5:08pm
8-K
EX-4.4
1p3x03ut8 8fuc
26 Feb 24
Other Events
5:08pm
8-K
EX-4.8
t8d38ejsdbdts54uf2ud
26 Feb 24
Other Events
5:08pm
8-K
EX-4.3
6rmratz4 md2h7je
26 Feb 24
Other Events
5:08pm
8-K
EX-4.5
qnmeh5
26 Feb 24
Other Events
5:08pm
8-K
EX-4.9
e22j29 8oq11
26 Feb 24
Other Events
5:08pm
8-K
EX-4.7
2h53uz
26 Feb 24
Other Events
5:08pm
8-K
EX-4.6
56y53w iuliut
26 Feb 24
Other Events
5:08pm
424B5
j6clgczht
26 Feb 24
Prospectus supplement for primary offering
6:12am
S-8
EX-4.5
w8ahreyfxm
22 Feb 24
Registration of securities for employees
5:50pm